Neuclone Makes Progress With Ustekinumab Trial

Australian Firm Hails Phase I Results For Stelara Rival

 
• By David Wallace
  
Phase_One
NeuClone has reported progress in its Phase I trial for ustekinumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products